focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.00
Ask: 5.50
Change: -0.25 (-5.00%)
Spread: 1.50 (37.50%)
Open: 5.00
High: 5.00
Low: 4.75
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Banking partnership with HSBC

18 Mar 2011 07:00

RNS Number : 1794D
Braveheart Investment Group plc
18 March 2011
 



18 March 2011

 

Braveheart Investment Group plc

 

Banking partnership with HSBC

 

Braveheart Investment Group (AIM: BRH) ('Braveheart' or the 'Group'), the AIM-listed specialist in growth capital investments for business angels, high net worth individuals and family offices, has entered into a banking partnership with HSBC Bank (the 'Bank'). The agreement involves the provision of credit facilities to the Group, operating accounts for both the Group and its clients, case by case specialist services and funding for portfolio companies. The partnership replaces that which the Group enjoyed with HBoS before it became part of Lloyds Banking Group.

 

Geoffrey Thomson, CEO of Braveheart, said: "We are pleased to announce this partnership. Given our increasingly international focus we felt it was important to work with a bank that offered clear expertise overseas as well as a strong footprint here in the UK. HSBC is developing its SME business in Scotland, where Braveheart has its headquarters, and understands how important the private company growth market is to the UK as a whole."

 

John Rendall, CEO of HSBC Scotland said: "We are delighted to welcome Braveheart Investment Group as a new client and provide them and their associated companies with the finance package and relationship-based banking approach to support their business growth. Our emphasis on providing relationship management through our Commercial division and within our branches continues to attract new customers to HSBC, and our international reach will undoubtedly provide Braveheart Investment Group with a seamless banking service as they look to develop their business overseas."

 

For further information please visit:

www.braveheartinvestmentgroup.co.uk

www.hsbc.co.uk

 

Or contact:

 

Braveheart Investment Group plc

Seymour Pierce

Geoffrey Thomson, Chief Executive

Tel: 01738 587555

gthomson@braveheart-ventures.co.uk

John Cowie (Nominated Adviser)

Jeremy Stephenson, Paul Jewell (Corporate Broking)

Tel: 020 7107 8000

 

HSBC Scotland

Media inquiries

Consolidated PR

Linda McIntyre

Tel: 0131 240 6420

hsbcscotland@consolidatedpr.com

 

Allerton Communications (for Braveheart)

Peter Curtain

Tel: 020 3137 2500

peter.curtain@allertoncomms.co.uk

 

 

Notes to editors

 

Braveheart Investment Group makes and manages investments in young, emerging British companies, specialising in building tax-efficient portfolios for business angels, high net worth individuals and family offices. Braveheart was founded in 1997 by a small group of investors to encourage and syndicate investments in privately held companies that offered opportunities for significant growth. Fourteen years on, Braveheart is a public company with a demonstrable track record in early-stage technology investing, an established client base and offices in Perth, London and Yorkshire.

 

Investments are made in unlisted companies where there is potential for significant growth through successful commercialisation of IP. Through close relationships with leading universities and innovation centres, Braveheart has access to a wide variety of emerging commercial opportunities at early stages. There are currently some 45 companies in Braveheart's diverse portfolio (includes all companies where the Group has a financial interest) and it has completed more than 100 deals.

 

Following the 2010 acquisition of Envestors Ltd, the London based specialist corporate finance advisory business, Braveheart has greater geographical reach and offers a unique and comprehensive suite of tax-efficient products to high-net-worth investors.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXDXFDLFEFF
Date   Source Headline
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
4th Nov 20208:52 amRNSExercise of Warrants and Issue of Equity
3rd Nov 202011:06 amRNSSecond Price Monitoring Extn
3rd Nov 202011:00 amRNSPrice Monitoring Extension
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
29th Oct 20204:40 pmRNSSecond Price Monitoring Extn
29th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Oct 20207:00 amRNSIssue of shares to certain directors and TVR
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:00 pmRNSPrice Monitoring Extension
23rd Oct 20207:00 amRNSUpdate on Pharm2Farm’s COVID-19 mask project
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202012:42 pmRNSFurther re. Conditional Sale of Pharm2Farm holding
19th Oct 202012:35 pmRNSPublication of Circular and Notice of GM
16th Oct 20207:00 amRNSFurther update re Paraytec Limited
8th Oct 20204:09 pmRNSUpdate on Pharm2Farm
5th Oct 202011:20 amRNSFurther update re Paraytec Limited
29th Sep 20204:40 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
24th Sep 20207:00 amRNSUpdate on Phasefocus Holdings Limited
18th Sep 20207:00 amRNSUpdate on the Pharm2Farm anti-viral mask project
8th Sep 202012:18 pmRNSResult of AGM
3rd Sep 20207:00 amRNSFurther re Paraytec Limited
28th Aug 20205:00 pmRNSTotal Voting Rights
21st Aug 20205:09 pmRNSConditional Sale of Pharm 2 Farm Limited holding
20th Aug 20201:04 pmRNSHolding(s) in Company
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 20207:00 amRNSFurther re Paraytec Limited
4th Aug 20207:00 amRNSFinal Results
23rd Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20207:18 amRNSParticipation in RMS placing
7th Jul 20207:00 amRNSFurther re Paraytec Limited
1st Jul 20202:31 pmRNSHolding(s) in Company
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20203:00 pmRNSAcquisition of 18.1% interest in RMS
19th Jun 20202:29 pmRNSOperational Update
9th Jun 20207:00 amRNSFurther re Paraytec Limited
8th Jun 20207:00 amRNSHolding(s) in Company
5th Jun 202012:44 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSAcquisition of Additional PhaseFocus Shares
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.